The step-wise or “continuous” nature of oncology innovation has fueled a debate on the value of new discoveries at a pivotal time when just the opposite is needed—policies that support and accelerate the discovery of better treatments and cures for patients.
Foster an understanding about the value of continuous innovation by helping policymakers, health economists, and other stakeholders visualize the step-wise nature of cancer progress and gain a better understanding of how value in cancer treatment evolves over time.
On the eve of World Cancer Day 2015, PACE launched the PACE Continuous Innovation IndicatorsTM (CII), a first-ever, evidence-based tool that aggregates 40 years of data against 12 cancers to cultivate a better understanding of how progress against cancer treatment evolves and how policies can support and speed up future innovation. The event was held at the Newseum in Washington, D.C., in collaboration with leading oncology organizations to drive a broader conversation about value in cancer care. The forum featured a panel of oncology experts and patient advocates who discussed how the CII could assist in identifying unmet needs and advancing future progress. The event was attended by more than 100 patient advocates, researchers, policy influencers and thought leaders. Media outreach efforts generated seven original articles, 120 million media impressions and op-ed placements in Forbes and The Hill.